KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,490,000 | -27.2% | 200,000 | 0.0% | 1.59% | -36.6% |
| Q2 2021 | $4,792,000 | -55.8% | 200,000 | -52.6% | 2.51% | -57.2% |
| Q1 2021 | $10,849,000 | +2732.6% | 422,310 | +1178.4% | 5.86% | +1475.3% |
| Q3 2019 | $383,000 | -87.5% | 33,033 | -76.1% | 0.37% | -79.2% |
| Q3 2018 | $3,053,000 | – | 138,100 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $13,155,000 | 11.03% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $2,974,000 | 3.14% |
| Vivo Capital, LLC | 1,476,796 | $11,297,000 | 1.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 227,433 | $1,731,000 | 0.79% |
| DAFNA Capital Management LLC | 234,952 | $1,797,000 | 0.75% |
| Samsara BioCapital, LLC | 168,174 | $1,287,000 | 0.74% |
| Ghost Tree Capital, LLC | 350,000 | $2,678,000 | 0.71% |
| Ikarian Capital, LLC | 946,605 | $7,242,000 | 0.54% |
| Opaleye Management Inc. | 225,000 | $1,721,000 | 0.46% |
| Eventide Asset Management | 1,680,000 | $12,852,000 | 0.42% |